160 related articles for article (PubMed ID: 31929115)
1. Metabolomic profiling of dried blood spots reveals gender-specific discriminant models for the diagnosis of small cell lung cancer.
Yu L; Li K; Li X; Guan C; Sun T; Zhang X
Aging (Albany NY); 2020 Jan; 12(1):978-995. PubMed ID: 31929115
[TBL] [Abstract][Full Text] [Related]
2. A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer.
Yu Z; Lu H; Si H; Liu S; Li X; Gao C; Cui L; Li C; Yang X; Yao X
PLoS One; 2015; 10(5):e0125517. PubMed ID: 25996920
[TBL] [Abstract][Full Text] [Related]
3. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer by Serum Metabolomic Profiling.
Tian Y; Wang Z; Liu X; Duan J; Feng G; Yin Y; Gu J; Chen Z; Gao S; Bai H; Wan R; Jiang J; Liu J; Zhang C; Wang D; Han J; Zhang X; Cai L; He J; Wang J
Clin Cancer Res; 2018 May; 24(9):2100-2109. PubMed ID: 29437793
[No Abstract] [Full Text] [Related]
5. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
7. New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer.
Nisman B; Nechushtan H; Biran H; Peled N; Gantz-Sorotsky H; Doviner V; Perelman M; Bar J; Onn A; Uziely B; Peretz T
Br J Cancer; 2016 Feb; 114(4):469-76. PubMed ID: 26812573
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation-based metabolomics profiling method for determining and quantitating cancer-related metabolites.
Yue X; He J; Zhang R; Xu J; Zhou Z; Zhang R; Bi N; Wang Z; Sun C; Wang L; Chen Y; Abliz Z
J Chromatogr A; 2018 Dec; 1580():80-89. PubMed ID: 30473010
[TBL] [Abstract][Full Text] [Related]
9. Differentiating Small-Cell Lung Cancer From Non-Small-Cell Lung Cancer Brain Metastases Based on MRI Using Efficientnet and Transfer Learning Approach.
Grossman R; Haim O; Abramov S; Shofty B; Artzi M
Technol Cancer Res Treat; 2021; 20():15330338211004919. PubMed ID: 34030542
[TBL] [Abstract][Full Text] [Related]
10. Identification of Small and Non-Small Cell Lung Cancer Markers in Peripheral Blood Using Cytokinesis-Blocked Micronucleus and Spectral Karyotyping Assays.
El-Zein RA; Abdel-Rahman S; Santee KJ; Yu R; Shete S
Cytogenet Genome Res; 2017; 152(3):122-131. PubMed ID: 28898877
[TBL] [Abstract][Full Text] [Related]
11. Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer.
Lu S; Kong H; Hou Y; Ge D; Huang W; Ou J; Yang D; Zhang L; Wu G; Song Y; Zhang X; Zhai C; Wang Q; Zhu H; Wu Y; Bai C
Lung Cancer; 2018 Sep; 123():44-51. PubMed ID: 30089594
[TBL] [Abstract][Full Text] [Related]
12. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
Du ZY; Shi MH; Ji CH; Yu Y
Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China.
Wu XY; Hu YB; Li HJ; Wan B; Zhang CX; Zhang B; Hu H; Zhang Q; Lv TF; Zhan P; Song Y
J Cell Mol Med; 2018 Sep; 22(9):4328-4334. PubMed ID: 29989303
[TBL] [Abstract][Full Text] [Related]
14. Plasma miR-92a-2 as a biomarker for small cell lung cancer.
Yu Y; Zuo J; Tan Q; Zar Thin K; Li P; Zhu M; Yu M; Fu Z; Liang C; Tu J
Cancer Biomark; 2017; 18(3):319-327. PubMed ID: 28106539
[TBL] [Abstract][Full Text] [Related]
15. Insulinoma-associated protein 1 is a novel diagnostic marker of small cell lung cancer in bronchial brushing and cell block cytology from pleural effusions: Validity and reliability with cutoff value.
Abe H; Takase Y; Sadashima E; Fukumitsu C; Murata K; Ito T; Kawahara A; Naito Y; Akiba J
Cancer Cytopathol; 2019 Sep; 127(9):598-605. PubMed ID: 31436913
[TBL] [Abstract][Full Text] [Related]
16. Application of Serum ELAVL4 (HuD) Antigen Assay for Small Cell Lung Cancer Diagnosis.
Wang F; Lu J; Li S; Huo X; Liu X; Du X; Li C; Wang J; Chen Z
Anticancer Res; 2017 Aug; 37(8):4515-4522. PubMed ID: 28739747
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract][Full Text] [Related]
18. Analyzing the percentage of different PD-1
Hu X; Gu Y; Li D; Zhao S; Hua S; Jiang Y
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1074-1083. PubMed ID: 31381177
[TBL] [Abstract][Full Text] [Related]
19. Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis.
Yang J; Jiao S; Kang J; Li R; Zhang G
Int J Clin Exp Pathol; 2015; 8(11):14959-64. PubMed ID: 26823828
[TBL] [Abstract][Full Text] [Related]
20. Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.
Xiang C; Jin S; Zhang J; Chen M; Xia Y; Shu Y; Guo R
Int J Biol Markers; 2018 Aug; 33(3):314-320. PubMed ID: 29896992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]